MOLECULAR-BIOLOGICAL PROBLEMS OF DRUG DESIGN AND MECHANISM OF DRUG ACTION HEPATOPROTECTIVE EFFICACY OF A NEW PHYTOCOMPOSITION OF ESSENTIAL PHOSPHOLIPIDS WITH GLYCYRRHIZIC ACID, ECDYSTERONE, AND LYCOPENE IN EXPERIMENTAL CHRONIC HEPATITIS COMPARED TO PHOSPHOGLIV

A phytocomposition of soy lecithin, glycyrrhizic acid, lycopene, and ecdysterone (conventional name Hepalipin) significantly prevents the development of cytolytic-cholestatic liver damage, contributes to the maintenance of protein- and glycogen-synthesizing functions of the liver, reduces its fatty degeneration, re-strains disorders of pigment metabolism, and exhibits an antioxidant effect when administered to experimental animals against the background of developing chronic toxic hepatitis caused by carbon tetrachloride. Hepalipin improves disturbed bile chemical composition and secretion. The continued administration of Hepalipin to rats for another two weeks after the cessation of carbon tetrachloride injections leads to almost complete restoration of all studied parameters to their initial (intact) values. Hepalipin under conditions of experimental chronic hepatitis showed statistically significant advantages compared to Phosphogliv in terms of the intensity of the hepatoprotective effect.